Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SHE/300181 stock hub

SHE/300181 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300181is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.6B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300181

In the news

Latest news · SHE/300181

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E16.7

P25 23.5P50 41.3P75 83.2

ROE19.8

P25 -0.9P50 4.1P75 8.8

ROIC20.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300181 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

CNY

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,125
Employees Change	-562%
Employees Change Percent	-20.92
Enterprise value	CNY 10.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CNE100001096
Last refreshed	2026-05-10
Market cap	CNY 10.6B
Price	CNY 15.22
Price currency	CNY
Rev Per Employee	1,465,475.56x
Sector	Healthcare
Sic	2834
Symbol	she/300181
Website	https://www.zuoli.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.16%
EV Earnings	16.33x
EV/EBIT	14.15x
EV/EBITDA	12.8x
EV/FCF	29.86x
EV/Sales	3.49x
FCF yield	3.37%
P/B ratio	3.02x
P/E ratio	16.73x
P/S ratio	3.39x
PE Ratio10 Y	66.1x
PE Ratio3 Y	20.64x
PE Ratio5 Y	24.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.89%
EBITDA Margin	27.35%
FCF margin	11.42%
Gross margin	62.09%
Gross Profit	CNY 1.9B
Gross Profit Growth	19.67%
Gross Profit Growth Q	14.15%
Gross Profit Growth3 Y	14.34%
Gross Profit Growth5 Y	18.13%
Net Income	CNY 650.4M
Net Income Growth	19.01%
Net Income Growth Q	10.18%
Net Income Growth Quarters	5%
Net Income Growth Years	7%
Net Income Growth3 Y	29.18%
Net Income Growth5 Y	39.83%
Pretax Margin	25.03%
Profit Margin	20.88%
Profit Per Employee	CNY 306,059
Profitable Years	19
ROA	9.79
Roa5y	8.01
ROCE	21.2
ROE	19.81
Roe5y	15.24
ROIC	20.51
Roic5y	18.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.07%
Cagr15y	11.83%
Cagr1y	0.08%
Cagr3y	8.89%
Cagr5y	19.9%
Div CAGR10	11.61%
Div CAGR3	44.22%
Div CAGR5	97.44%
EPS Growth	19.19
EPS Growth Q	10.18
EPS Growth Quarters	5
EPS Growth Years	7
EPS Growth3 Y	25.05
EPS Growth5 Y	36.17
FCF Growth3 Y	57.41%
FCF Growth5 Y	5.91%
OCF Growth	181.05%
OCF Growth10 Y	17.66%
OCF Growth3 Y	32.47%
OCF Growth5 Y	11.7%
Revenue Growth	14.1x
Revenue Growth Q	8.9x
Revenue Growth Quarters	24x
Revenue Growth Years	8x
Revenue Growth3 Y	18.71x
Revenue Growth5 Y	20.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.63
Assets	CNY 5.3B
Cash	CNY 718.3M
Current Assets	CNY 2.6B
Current Liabilities	CNY 1.7B
Debt	CNY 766.5M
Debt EBITDA	CNY 0.9
Debt Equity	CNY 0.22
Debt FCF	CNY 2.15
Equity	CNY 3.5B
Interest Coverage	53.67
Liabilities	CNY 1.8B
Long Term Assets	CNY 2.7B
Long Term Liabilities	CNY 162.4M
Net Cash	CNY -48.2M
Net Cash By Market Cap	CNY -0.46
Net Debt EBITDA	CNY 0.06
Net Debt Equity	CNY 0.01
Net Debt FCF	CNY 0.14
Tangible Book Value	CNY 2.8B
Tangible Book Value Per Share	CNY 4.03
WACC	5.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.55
Inventory Turnover	2.27
Net Working Capital	CNY 923.9M
Quick ratio	1.19
Working Capital	CNY 923.2M
Working Capital Turnover	CNY 2.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.16%
Dividend Growth	33.33%
Dividend Growth Years	5%
Dividend per share	CNY 0.35
Dividend Years	14
Dividend Yield	2.3%
Ex Div Date	2025-05-26
Last Dividend	CNY 0.6
Payout Frequency	Annual
Payout Ratio	64.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	97.98%
1Y total return	0.07%
200-day SMA	17.41
3Y total return	29.12%
50-day SMA	15.9
50-day SMA vs 200-day SMA	50under200
5Y total return	147.76%
All Time High	21.07
All Time High Change	-27.76%
All Time High Date	2025-08-19
All Time Low	2.63
All Time Low Change	478.93%
All Time Low Date	2011-06-22
ATR	0.4
Beta	0.22
Beta1y	0.27
Beta2y	0.4
Ch YTD	-5.82
High	15.29
High52	21.07
High52 Date	2025-08-19
High52ch	-27.76%
Low	15.17
Low52	14.81
Low52 Date	2026-03-27
Low52ch	2.77%
Ma50ch	-4.25%
Price vs 200-day SMA	-12.59%
RSI	42.91
RSI Monthly	48.69
RSI Weekly	38.77
Sharpe ratio	-0.17x
Sortino ratio	-0.06
Total Return	4.1%
Tr YTD	-5.82
Tr15y	435.1%
Tr1m	-0.78%
Tr3m	-13.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 775.1M
Operating Income Growth	22.04
Operating Income Growth Q	16.89
Operating Income Growth3 Y	33.12
Operating Income Growth5 Y	39.08
Operating margin	24.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	533,310,858%
Net Borrowing	211,401,154
Shares Insiders	22.1%
Shares Institutions	10.61%
Shares Out	693,217,261
Shares Qo Q	4.12%
Shares Yo Y	-0.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 355.8M
Average Volume	11,645,326.3x
Bv Per Share	4.88
CAPEX	CNY -213.5M
Ch10y	69.3
Ch15y	337.1
Ch1m	-0.78
Ch1y	-3.55
Ch3m	-13.08
Ch3y	18.17
Ch5y	118.4
Ch6m	-13.18
Change	0.2%
Change From Open	0.07
Close	15.19
Days Gap	0.13
Depreciation Amortization	78,770,251
Dollar Volume	119,462,054
Earnings Date	2026-04-27
EBIT	CNY 775.1M
EBITDA	CNY 851.7M
EPS	CNY 0.94
F Score	5
FCF	CNY 355.8M
FCF EV Yield	3.35x
FCF Per Share	CNY 0.51
Financing CF	-186,199,984
Fiscal Year End	December
Founded	1,995
Goodwill	321,365,851
Graham Number	10.14368
Graham Upside	-33.35
Income Tax	CNY 118.5M
Investing CF	-385,093,194
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2015-05-20
Last Split Type	Forward
Lynch Fair Value	CNY 23.41
Lynch Upside	53.84
Ma150	16.88
Ma150ch	-9.83%
Ma20	15.64
Ma20ch	-2.69%
Net CF	-2,045,801
Next Earnings Date	2026-07-30
Open	15.21
P FCF Ratio	29.66
P OCF Ratio	18.53
Payment Date	2025-05-26
Position In Range	41.67
Ppne	1,483,974,359
Price Date	2026-05-08
Price EBITDA	CNY 12.39
Ptbv Ratio	3.74
Relative Volume	0.68x
Revenue	3,114,135,556x
Tax By Revenue	3.8x
Tax Rate	15.2%
Tr6m	-13.18%
Volume	7,849,018

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300181 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$0.35 annual per share

Payout ratio

+64.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+97.4%

5 consecutive years of growth

Total shareholder yield

+2.5%

Next ex-dividend date: 2025-05-26

Performance

SHE/300181 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300181?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.6%

Share of float held by funds and institutions

Insider ownership

+22.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

SHE/300181 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.9

Neutral momentum band

Price vs 200-day MA

-12.6%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

-0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300181

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300181 stock rating?

she/300181 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300181 analysis?

The full report lives at /stocks/she/300181/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300181?

The latest report frames she/300181 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300181 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.